Skip to main content

Table 1 Baseline characteristics of 338 HCC patients

From: Ability of the ALBI grade to predict posthepatectomy liver failure and long-term survival after liver resection for different BCLC stages of HCC

Variables Total cohort
(n = 338)
BCLC 0/A HCC
(n = 205)
BCLC B/C HCC
(n = 133)
Age, years 52 (44–66) 52 (44–60) 52 (43–60)
Male gender 299 (88.5) 180 (87.5) 119 (89.5)
Positive HBsAg 278 (82.2) 170 (82.9) 108 (81.2)
Total bilirubin, μmol/l 14.0 (13.4–19.4) 13.9 (10.0–19.6) 14.4 (10.6–18.7)
Albumin, g/l 37.9 (35.1–40.8) 38.0 (35.4–41.0) 37.6 (34.0–40.7)
ALT, U/l 36.1 (25.8–52.0) 34.3 (24.7–53.0) 37.9 (26.4–51.0)
Prothrombin time, s 13.2 (12.0–14.1) 13.2 (12.0–14.1) 13.2 (12.1–14.1)
INR 1.04 (0.95–1.14) 1.04 (0.94–1.14) 1.05 (0.95–1.14)
Platelet count, × 109/l 155 (110–205) 155 (110–211) 154 (113.5–201.5)
Maximum tumor size, cm 6.0 (4.2–10.0) 6.0 (3.5–9.2) 8 (5.0–11.0)
Serum AFP, ng/ml
 ≥ 400 141 (41.7) 73 (35.6) 68 (51.1)
 < 400 197 (58.3) 132 (64.4) 65 (48.9)
CSPH 56 (16.6) 34 (16.6) 22 (16.5)
ALBI score − 2.460 (− 2.704– − 2.192) − 2.518 (−  2.719–− 2.236) − 2.399 (− 2.702–− 2.136)
ALBI grade
 1 134 (39.6) 89 (43.4) 45 (33.8)
 2 198 (58.6) 114 (55.6) 84 (63.2)
 3 6 (1.8) 2 (1.0) 4 (3.0)
MELD score (range) 7 (6–18) 7 (6–18) 7 (6–17)
MELD score
 ≥ 9 88 (26.0) 47 (22.9) 41 (30.8)
 < 9 250 (74.0) 158 (77.1) 92 (69.2)
Child-Pugh grade
 A 308 (91.1) 190 (92.7) 118 (88.7)
 B 30 (8.9) 15 (7.3) 15 (11.3)
 C 0 (0) 0 (0) 0 (0)
BCLC stage
 0 12 (3.6)
 A 193 (57.1)
 B 82 (24.3)
 C 51 (15.1)
  1. HCC hepatocellular carcinoma, HBsAg hepatitis B surface antigen, ALT alanine aminotransferase, INR international normalized ratio, AFP α-fetoprotein, CSPH clinically significant portal pressure, ALBI albumin-bilirubin, BCLC Barcelona Clinic Liver Cancer
  2. †Values are median (interquartile range)
  3. ‡Values are number (%)